Hydrolyzed Collagen Peptide Market latest Statistics on Market Size, Growth, Production, Sales Volume, Sales Price, Market Share and Import vs Export

Functional Nutrition Expansion and Beauty Supplement Consumption Push Global Collagen Ingredient Demand Beyond 1.8 Million Tons

The Hydrolyzed Collagen Peptide market is valued at approximately USD 1.74 billion in 2026 and is projected to reach nearly USD 2.96 billion by 2032, expanding at a CAGR of 9.2% during the forecast period. Growth is supported by increasing consumption of protein-enriched nutraceuticals, functional beverages, sports recovery formulations, anti-aging supplements, and clinical nutrition products. Hydrolyzed collagen peptides continue gaining preference because of their high bioavailability, neutral flavor profile, rapid solubility, and compatibility across powder, liquid, capsule, and ready-to-drink applications. Demand from Asia-Pacific, North America, and Western Europe remains the primary growth contributor due to expanding preventive healthcare spending and aging populations.

Production activity is also increasing across bovine, porcine, marine, and poultry-derived collagen processing facilities. In February 2025, GELITA expanded collagen peptide production capacity in Brazil by approximately 18,000 metric tons annually to support rising export demand from sports nutrition and beauty supplement manufacturers in the United States and Europe. Similarly, in October 2024, Rousselot announced additional peptide processing investments in France and China aimed at improving pharmaceutical-grade collagen output. These developments directly strengthen supply availability while stabilizing long-term procurement contracts for nutraceutical brands. The Hydrolyzed Collagen Peptide market is also influenced by rising raw material optimization in meat processing industries, where collagen extraction efficiency and sustainable by-product utilization are becoming critical profitability drivers.

Global prices for food-grade hydrolyzed collagen peptides currently range between USD 8,200 and USD 14,500 per metric ton depending on source material, peptide purity, molecular weight distribution, and application-specific certifications. Marine-derived variants continue trading at premium pricing due to limited fish skin availability and increasing demand from halal and pescatarian product manufacturers. Rising investments in clinical nutrition and cosmetic ingestibles are expected to maintain stable long-term demand momentum across the Hydrolyzed Collagen Peptide market.

Key Statistics at a Glance

• Global Hydrolyzed Collagen Peptide market value stands at approximately USD 1.74 billion in 2026.
• Total global collagen peptide production exceeds 1.8 million metric tons in 2026.
• Asia-Pacific accounts for nearly 39% of total collagen peptide consumption volume.
• Nutraceutical applications contribute around 42% of total market revenue share.
• Marine collagen peptide prices remain 28%–35% higher than bovine-derived variants.
• Sports nutrition applications are expanding at an estimated CAGR of 11.4% through 2032.
• Pharmaceutical-grade collagen peptides represent approximately 14% of total production volume.
• In March 2025, Nitta Gelatin increased peptide processing capacity in India by nearly 9,000 tons annually.
• Europe accounts for over 31% of premium cosmetic collagen supplement demand.
• Average hydrolyzed collagen peptide export prices from Brazil increased by 7.8% during 2025 due to higher global procurement activity.
• Functional beverage manufacturers increased collagen ingredient procurement volumes by nearly 16% in 2025.
• Marine collagen production utilization rates in Southeast Asia exceeded 81% during late 2025 due to export demand growth.

Definitions and Scope of the Hydrolyzed Collagen Ingredient Industry

Hydrolyzed collagen peptide refers to enzymatically processed collagen protein that is broken down into smaller peptide chains for enhanced digestion, solubility, and absorption. These peptides are derived primarily from bovine hides, porcine skin, fish skin, fish scales, poultry cartilage, and bone materials through hydrolysis and purification processes. The resulting ingredients are widely incorporated into nutraceutical formulations, functional foods, beverages, cosmetics, pharmaceutical preparations, sports recovery products, and medical nutrition formulations.

The Hydrolyzed Collagen Peptide market measures commercial production, processing, trade, pricing, and consumption of collagen peptides across industrial applications. Market valuation includes food-grade, pharmaceutical-grade, cosmetic-grade, and specialty collagen peptide formulations supplied through B2B ingredient channels and branded consumer products. The scope covers both powder and liquid peptide formats distributed globally through direct industrial procurement and retail supplement channels.

The analysis period focuses on 2026 as the base year, while forecasts extend through 2032. Market assessment includes production trends, raw material sourcing, peptide processing technologies, regional trade patterns, manufacturing investments, demand by application sector, and pricing movement across major producing countries.

Industries covered within the scope include:

• Nutraceuticals and dietary supplements
• Functional beverages
• Sports nutrition
• Clinical nutrition
• Pharmaceutical excipients
• Cosmetic ingestibles
• Personal care formulations
• Pet nutrition
• Functional bakery and confectionery products

The Hydrolyzed Collagen Peptide market is influenced heavily by health and wellness spending patterns. Aging populations in Japan, Germany, Italy, South Korea, and the United States continue driving collagen supplementation demand related to bone health, skin elasticity, joint support, and muscle recovery. At the same time, younger consumer demographics are increasing adoption of beauty-from-within products and protein-enriched beverages.

Production economics are closely tied to livestock processing output and marine raw material availability. Countries with strong meat processing industries such as Brazil, the United States, China, and Germany maintain significant competitive advantages due to stable bovine and porcine collagen feedstock supply. Marine collagen production is concentrated in Japan, Vietnam, Thailand, China, and Norway because of established seafood processing ecosystems.

In June 2025, Darling Ingredients announced additional investments exceeding USD 95 million across collagen and gelatin processing operations in North America to improve extraction efficiency and increase specialty peptide production. Such investments directly support supply chain integration and higher-value protein ingredient manufacturing. Similarly, in September 2024, China introduced updated functional food registration guidelines supporting broader nutraceutical ingredient commercialization, accelerating collagen peptide product launches across domestic supplement brands.

Application diversification is another important component within market scope. Initially concentrated in capsules and powdered supplements, collagen peptides are now increasingly integrated into protein bars, dairy alternatives, energy beverages, gummies, and fortified confectionery products. This diversification significantly increases industrial procurement volumes.

Regulatory compliance also shapes market structure. Pharmaceutical and clinical nutrition applications require strict microbial testing, traceability systems, and molecular weight consistency. Premium manufacturers therefore invest heavily in filtration systems, enzymatic processing controls, and quality certification programs including ISO, GMP, NSF, halal, and kosher approvals.

The Hydrolyzed Collagen Peptide market additionally reflects sustainability trends within food ingredient manufacturing. Meat processing companies increasingly monetize by-products through collagen extraction rather than waste disposal, improving profitability and circular economy integration. Marine collagen manufacturers are similarly utilizing fish skin and scale waste generated from seafood processing facilities to produce high-value protein ingredients with lower environmental impact.

Regional demand patterns remain uneven due to differences in dietary supplement penetration, disposable income, cosmetic consumption, and preventive healthcare awareness. North America and Europe dominate premium-value segments, while Asia-Pacific leads overall volume growth because of expanding middle-class nutrition spending and increasing domestic manufacturing capacity.

Sector-Wise Breakdown

Nutraceutical and Dietary Supplement Industry

Nutraceutical applications account for nearly 42% of total global collagen peptide consumption revenue.

• More than 620,000 metric tons of hydrolyzed collagen peptides are consumed annually in dietary supplements and wellness formulations.
• Capsule and powder supplement formats contribute approximately 68% of nutraceutical collagen sales volume.
• Asia-Pacific nutraceutical collagen demand is increasing at nearly 10.8% annually due to preventive healthcare adoption.
• Beauty supplement launches containing collagen peptides increased by 19% globally during 2025.

The nutraceutical segment remains the largest contributor to the Hydrolyzed Collagen Peptide market because of expanding consumer preference for preventive nutrition and healthy aging products. Collagen peptides are increasingly incorporated into skin health supplements, bone support formulations, mobility products, and daily wellness nutrition blends. The strongest demand growth is observed among consumers aged above 35 years, particularly in Japan, South Korea, Germany, and the United States.

In April 2025, Japan-based Shiseido expanded ingestible beauty supplement production by adding new collagen peptide sourcing agreements across Southeast Asia. This development increased regional procurement activity for marine collagen ingredients. Similarly, in August 2024, Nestlé Health Science expanded collagen-fortified nutritional supplement distribution across Europe, directly increasing industrial peptide demand from contract ingredient suppliers.

The Hydrolyzed Collagen Peptide market benefits from rising product diversification within gummies, sachets, stick packs, and ready-to-mix beverages. Premiumization trends also support higher margins for low-molecular-weight and marine-derived peptide formulations.

Functional Food and Beverage Manufacturing

Functional food and beverage applications contribute approximately 24% of total collagen peptide demand volume globally.

• Functional beverage collagen inclusion rates increased by nearly 16% during 2025.
• Ready-to-drink protein beverages account for around 31% of food-grade peptide utilization.
• North American collagen-enriched snack launches increased by 14% between 2024 and 2025.
• Food-grade peptide production utilization rates exceeded 79% globally in late 2025.

Food and beverage manufacturers increasingly use collagen peptides because of their neutral taste, high dispersibility, and compatibility with low-sugar nutritional products. Protein-fortified coffee, dairy alternatives, protein waters, confectionery products, and fortified bakery applications are becoming major growth categories.

In March 2025, PepsiCo expanded high-protein beverage production capacity in the United States, increasing procurement demand for functional protein ingredients including collagen peptides. In November 2024, several South Korean beverage manufacturers introduced collagen-infused wellness drinks targeting anti-aging and skin hydration applications, further supporting regional demand growth.

The Hydrolyzed Collagen Peptide market is also supported by consumer preference for clean-label proteins compared with synthetic additives. Food manufacturers increasingly position collagen peptides as multifunctional ingredients combining protein enrichment, texture stabilization, and wellness-oriented marketing benefits.

Pharmaceutical and Clinical Nutrition Applications

Pharmaceutical and clinical nutrition sectors represent nearly 14% of total global collagen peptide production.

• Clinical nutrition demand for collagen peptides is growing at approximately 8.7% annually.
• Pharmaceutical-grade collagen peptide pricing remains 22%–30% higher than standard food-grade variants.
• Europe accounts for nearly 37% of regulated medical nutrition peptide consumption.
• Hospital nutrition procurement volumes increased by 11% during 2025.

Clinical and pharmaceutical applications continue expanding due to increasing use of collagen peptides in wound healing formulations, geriatric nutrition, orthopedic recovery products, and medical nutrition supplements. These applications require strict purity specifications, traceability systems, and microbial safety compliance.

In January 2025, Rousselot expanded pharmaceutical-grade collagen peptide manufacturing capabilities in France to meet increasing clinical nutrition demand from European healthcare suppliers. In July 2024, Germany increased reimbursement support for elderly nutritional care programs, indirectly supporting demand for protein-enriched medical formulations containing collagen peptides.

The Hydrolyzed Collagen Peptide market benefits from rising healthcare expenditure associated with aging populations and chronic musculoskeletal conditions. Clinical nutrition manufacturers increasingly prioritize hydrolyzed collagen because of high digestibility and low allergenic risk compared with several conventional protein sources.

Cosmetics and Personal Care Sector

Cosmetic and beauty applications account for nearly 12% of premium collagen peptide revenue globally.

• Marine collagen peptides represent over 58% of cosmetic-sector collagen ingredient demand.
• South Korea and Japan together account for nearly 34% of beauty collagen supplement consumption.
• Premium beauty collagen prices increased by approximately 6.4% during 2025.
• Cosmetic ingestible product launches increased by 21% globally between 2024 and 2025.

The cosmetics sector remains one of the highest-value segments within the Hydrolyzed Collagen Peptide market due to strong demand for skin elasticity, hydration, and anti-aging formulations. Marine-derived peptides are particularly preferred because of higher consumer acceptance in beauty products and lower perceived contamination risks.

In October 2025, Amorepacific expanded production of collagen-based nutricosmetic products in South Korea following strong domestic and export demand growth. European luxury beauty brands are also increasing procurement of sustainably sourced marine peptides to align with clean beauty positioning strategies.

Long-term sector growth is supported by increasing crossover between cosmetics, wellness, and nutrition industries. Manufacturers are developing integrated beauty-from-within product portfolios combining collagen peptides with hyaluronic acid, biotin, antioxidants, and vitamin complexes.

Table: Sector vs Percentage Impact/Exposure in the Hydrolyzed Collagen Peptide Industry

Sector	Estimated Market Exposure Share (%)
Nutraceuticals and Dietary Supplements	42%
Functional Food and Beverages	24%
Pharmaceutical and Clinical Nutrition	14%
Cosmetics and Personal Care	12%
Sports Nutrition	5%
Pet Nutrition and Others	3%

Regional and Country Comparison

Asia-Pacific accounts for approximately 39% of global Hydrolyzed Collagen Peptide market demand, followed by Europe at 28%, North America at 24%, and the remaining share distributed across Latin America and the Middle East & Africa. Regional performance varies according to livestock processing capacity, supplement penetration, seafood processing activity, and healthcare spending patterns.

China remains the largest production and consumption center in Asia-Pacific due to its integrated meat processing industry and rapidly expanding nutraceutical sector. Chinese collagen peptide output exceeds 420,000 metric tons annually. In September 2025, China approved multiple new functional nutrition registrations supporting collagen-enriched supplement commercialization. Domestic beauty supplement sales growth and expanding sports nutrition consumption continue supporting local manufacturing investments.

Japan remains a premium-value market with strong demand for marine collagen peptides. More than 48% of Japanese beauty supplements contain collagen-related ingredients. In May 2025, Japanese seafood processors expanded marine collagen extraction facilities in Hokkaido following rising export demand from cosmetic ingredient buyers across Southeast Asia and Europe.

India is emerging as a competitive production location due to lower manufacturing costs and expanding pharmaceutical ingredient capabilities. In March 2025, Nitta Gelatin expanded peptide manufacturing capacity in Gujarat by approximately 9,000 metric tons annually. This expansion supports both domestic nutraceutical demand and export opportunities to the Middle East and Europe.

North America contributes approximately 24% of global revenue within the Hydrolyzed Collagen Peptide market. The United States dominates regional demand because of high supplement consumption, sports nutrition spending, and advanced clinical nutrition industries. More than 74% of collagen supplement sales in North America are concentrated in powder-based products. In February 2025, Darling Ingredients invested additional capital into collagen extraction optimization facilities in the United States to improve specialty peptide output and export competitiveness.

Europe maintains strong pharmaceutical and cosmetic collagen demand supported by aging demographics and premium wellness consumption. Germany, France, Italy, and the United Kingdom collectively account for over 63% of European collagen peptide utilization. In October 2024, France-based Rousselot expanded specialty peptide processing infrastructure targeting pharmaceutical and medical nutrition applications across Western Europe.

Brazil is one of the largest exporters of bovine-derived collagen peptides because of abundant livestock processing capacity. Brazilian production benefits from integrated beef supply chains and competitive raw material access. In February 2025, GELITA expanded production operations in Brazil to strengthen export supply to North America and Europe. This expansion increased regional production competitiveness while improving global supply availability.

Southeast Asia continues gaining importance within marine collagen production. Vietnam and Thailand benefit from seafood processing industries that provide collagen extraction feedstock from fish skin and scales. Marine collagen utilization rates across Southeast Asia exceeded 81% during late 2025 due to rising international procurement from premium cosmetic and nutraceutical manufacturers.

The Middle East is witnessing moderate growth due to rising halal-certified collagen demand, particularly in the United Arab Emirates and Saudi Arabia. Demand is increasingly linked to premium wellness supplements and functional beverages targeting younger urban consumers.

Future Outlook

The Hydrolyzed Collagen Peptide market is projected to maintain stable long-term growth due to rising demand from preventive healthcare, sports nutrition, healthy aging products, and functional food applications. Expanding awareness regarding joint health, skin elasticity, muscle recovery, and protein supplementation continues supporting industrial demand across both developed and emerging economies.

• Global market revenue is projected to grow at a CAGR of 8.5%–10.5% between 2026 and 2032, with overall valuation expected to surpass USD 3 billion by the end of the forecast period.
• Asia-Pacific is expected to maintain the largest consumption share at approximately 40%–43% through 2032, supported by increasing nutraceutical spending in China, Japan, India, and South Korea.
• Marine-derived collagen peptides are projected to witness annual demand growth above 11% due to rising beauty supplement consumption and increasing preference for sustainable marine-based ingredients.
• Pharmaceutical and clinical nutrition applications are forecast to expand at 8%–9% annually as aging populations increase demand for therapeutic nutrition and recovery-focused protein products.
• Functional beverage applications are expected to remain one of the fastest-growing categories, with collagen inclusion in ready-to-drink nutritional beverages projected to increase by nearly 35%–40% by 2030.
• Premium low-molecular-weight collagen peptides are expected to gain higher market share because of increasing scientific validation related to absorption efficiency and targeted wellness benefits.

Production investments are also expected to increase significantly across Brazil, India, China, and Southeast Asia due to strong raw material availability and export-oriented manufacturing advantages. Sustainability initiatives linked to meat and seafood by-product utilization will continue influencing procurement decisions among major nutraceutical and cosmetic brands.

Technological improvements in enzymatic hydrolysis, purification systems, and peptide customization are expected to improve product consistency and expand pharmaceutical-grade applications. Manufacturers are increasingly focusing on clinically validated formulations, traceability systems, and clean-label certifications to strengthen competitive positioning.

Market Players and Market Share Analysis

The Hydrolyzed Collagen Peptide market is moderately consolidated, with several multinational manufacturers controlling a substantial portion of global production capacity. Large producers maintain advantages through vertically integrated supply chains, established distribution networks, advanced peptide processing technologies, and strong regulatory compliance capabilities.

The top five manufacturers collectively account for approximately 48%–55% of global market revenue. However, regional manufacturers continue gaining market presence in marine collagen and specialty peptide categories, particularly across Asia-Pacific and Scandinavia.

Major companies operating in the market include:

• GELITA AG
• Rousselot
• Nitta Gelatin Inc.
• PB Leiner
• Darling Ingredients
• GELNEX
• Weishardt Group
• Lapi Gelatine
• Jellice Group
• Titan Biotech
• Seagarden
• BioCell Technology
• Collagen Solutions

GELITA AG remains one of the leading participants in the Hydrolyzed Collagen Peptide market, accounting for an estimated 14%–16% global share. The company maintains strong positioning across sports nutrition, medical nutrition, and beauty supplement applications. Its product portfolio includes specialized collagen peptide formulations targeting mobility support, skin health, and muscle recovery.

Rousselot maintains an estimated global share of approximately 11%–13%, supported by strong presence in pharmaceutical-grade peptides and clinical nutrition applications. The company continues expanding specialty peptide production capacity in Europe and Asia to support regulated healthcare markets.

Nitta Gelatin Inc. continues strengthening its position across Asia-Pacific and India through capacity expansion and pharmaceutical-grade production capabilities. The company benefits from growing demand across nutraceuticals, cosmetics, and therapeutic nutrition sectors.

PB Leiner remains an important supplier within Europe and Latin America, supported by strong bovine raw material integration and diversified application exposure. The company maintains stable participation across food processing, pharmaceutical, and wellness ingredient markets.

Darling Ingredients is increasing strategic investments in collagen extraction and specialty peptide manufacturing. The company benefits from integrated raw material sourcing and growing participation in premium wellness ingredient categories.

Marine collagen production remains comparatively fragmented because of regional dependence on seafood processing infrastructure. Manufacturers located in Japan, Vietnam, Thailand, Norway, and China are increasing investments in fish skin and scale extraction technologies to meet rising demand from cosmetic and nutraceutical industries.

Competition within the Hydrolyzed Collagen Peptide market is increasingly influenced by:

• Sustainable sourcing capabilities
• Halal and kosher certifications
• Pharmaceutical-grade quality standards
• Clinical validation studies
• Customized peptide formulations
• Long-term procurement agreements with wellness brands
• Low-molecular-weight peptide specialization

The industry is also witnessing increased collaboration between ingredient manufacturers and branded supplement companies. Strategic partnerships are helping producers secure stable demand volumes while improving downstream market penetration across sports nutrition, healthy aging, and beauty supplement categories.

Smaller regional producers continue competing through lower manufacturing costs and niche marine collagen offerings. However, multinational companies maintain stronger advantages in research capabilities, regulatory approvals, large-scale production economics, and global distribution access.

Latest News and Industry Developments

• In February 2025, GELITA AG expanded collagen peptide production capacity in Brazil to support increasing export demand from North American and European nutraceutical manufacturers.
• In March 2025, Nitta Gelatin India increased peptide processing capacity in Gujarat to strengthen pharmaceutical and nutraceutical ingredient exports from India.
• In October 2024, Rousselot expanded specialty collagen peptide manufacturing infrastructure in France and China focusing on pharmaceutical-grade and clinical nutrition applications.
• In 2025, several sports nutrition manufacturers across the United States and Europe increased procurement of low-molecular-weight collagen peptides for recovery beverages and protein supplement formulations.
• During late 2025, marine collagen producers in Vietnam and Thailand expanded fish-skin peptide extraction capacity following increased export demand from cosmetic ingredient companies in Japan and Europe.
• In September 2025, China introduced additional support measures for functional nutrition product commercialization, accelerating domestic collagen supplement launches and ingredient procurement activity.
• In 2025, major beauty supplement brands in South Korea expanded collagen-infused ingestible product lines targeting skin hydration and anti-aging applications, supporting higher regional marine collagen consumption.
• In 2024 and 2025, several European clinical nutrition companies increased investments in therapeutic protein formulations incorporating hydrolyzed collagen peptides for elderly nutrition and orthopedic recovery applications.